tenk.fyi

Acumen Pharmaceuticals, Inc.

ABOSNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$102.3M

95.4% YoY

EPS

$-1.71

58.3% YoY

Cash

$35.6M

46.7% YoY

FY 2024 · As of 2024-12-31